Copyright
©The Author(s) 2023.
World J Diabetes. May 15, 2023; 14(5): 512-527
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.512
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.512
Involved mechanism | Result | |
Structural remodelling | Inflammation | Atrial fibrosis and dilatation |
Oxidative stress | ||
Expression of profibrotic growth factors | ||
Enhanced collagen synthesis and high fibroblast activity | ||
Activation of the (RAAS) system | ||
Obesity and adiposity | ||
Electrical remodelling | Longer activation times | Conduction abnormalities |
Abnormal current densities and refractory periods | ||
Electromechanical delay | ||
Affected gap junction function | ||
Autonomic dysfunction | Downsizing of parasympathetic nervous system | Autonomic imbalance |
Upregulation of sympathetic stimuli | ||
Glycemic parameters | Sympathetic activation due to hypoglycaemia | AF susceptibility |
Remodelling due to chronic hyperglycemia | ||
Oxidative stress and fibrosis due to glycemic fluctuations | ||
Fibrosis due to adipokines |
- Citation: Leopoulou M, Theofilis P, Kordalis A, Papageorgiou N, Sagris M, Oikonomou E, Tousoulis D. Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment. World J Diabetes 2023; 14(5): 512-527
- URL: https://www.wjgnet.com/1948-9358/full/v14/i5/512.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i5.512